Germany’s BioNTech to buy CureVac to boost cancer research
Frankfurt (Germany) (AFP) - Germany's BioNTech is buying domestic rival CureVac for $1. 25 billion, the companies said Thursday, bringing ...
Tuesday, May 12, 2026
Tag: mrna technology
We bring the world economy to you. Get the latest news and insights on the global economy, from trade and finance to technology and innovation.